Family studies demonstrated the contribution of genetic factor to the development of essential hypertension. While the familial component of blood pressure（BP） is well described, the risk of hypertension developing as a result of family history has not been well quantified 1） . The heritage portion of blood pressure is estimated to range between 35％ and 65％ 2） -4） . Genetic polymorphisms are related to hypertension. Genes coded in the components of renin-angiotensin-aldosteron system（RAAS） are crucial in the pathogenesis of essensial hypertension via the blood pressure management. Epidemiological studies have suggested that nucleotide sequence variations of genes such as angiotensinogen（AGT）, renin（REN）, angiotensin-converting enzyme （ACE）, angiotensin II receptor type I（AT─1R ） and aldosterone synthase（CYP11B2） are associated with the risk of essensial hypertension shown that D allele and the association with higher prevalence of hypertension is still an issue of debate and not established. There was a wide ethnic variation in ACE gene polymorphism. The objective of the present study was to investigate ACE I／ D gene 287 bp polymorphism among hypertensive subjects with and without a history of family hypertension in a Javanese population. A cross sectional study was conducted in a community-based study in the districts of Sleman─Yogyakarta. There were 12, 073 subjects more than 17 years old and 7695 in the 30─59 age range. Subjects were grouped as normotension, pre-hypertension and hypertension. Stratified randomized sampling was conducted to select 82 subjects with familial hypertension and 74 with non-familial hypertension in this study. Genotypes of the ACE gene polymorphisms（II／ID／DD） were determined using polymerase chain reaction（PCR） at the Biochemistry Laboratory, Faculty of Medicine Gadjah Mada University, Yogyakarta, Indonesia. The results showed that genotypic frequencies in the familial group versus the non-familial were 42（51. 2％） vs 57 （77％） II, 36 （43. 9％） vs 15 （20. 3％） ID and 4 （5％） vs 2 （2. 7％） DD, p=0. 002. The allelic frequencies were 120 （73. 2％） vs 129（87. 2％） I and 44（26. 8％） vs 19（12. 8％） D allele, p=0. 002. The genotype frequency in men with familial hypertension was higher than that of the non-familial group 22（47. 9％） vs 8（21. 6％） ID, p=0. 004. Frequencies of D allele ACE gene and DD／ID genotypes in familial hypertensive subjects were higher than in non-familial subjects. The D allele frequency in women in the familial hypertensive group was higher than that in the non-familial group.
Introduction
Family studies demonstrated the contribution of genetic factor to the development of essential hypertension. While the familial component of blood pressure（BP） is well described, the risk of hypertension developing as a result of family history has not been well quantified 1） . The heritage portion of blood pressure is estimated to range between 35％ and 65％ 2） -4） . Genetic polymorphisms are related to hypertension. Genes coded in the components of renin-angiotensin-aldosteron system（RAAS） are crucial in the pathogenesis of essensial hypertension via the blood pressure management. Epidemiological studies have suggested that nucleotide sequence variations of genes such as angiotensinogen（AGT）, renin（REN）, angiotensin-converting enzyme （ACE）, angiotensin II receptor type I（AT─1R ） and aldosterone synthase（CYP11B2） are associated with the risk of essensial hypertension 5） . The ACE insertion／deletion （I／D） gene polymorphism and a predisposition to hypertension have been shown in many studies. More than 100 polyOriginal Articles Juntendo Medical Journal 2012. 58 （3） , 224-230 morphisms have been identified on locus of ACE, which is located on chromosome 17q23 and related with high blood pressure in some studies. The most popular polymorphism is an insertion／dele-tion（I／D） of a 287-bp DNA fragment in intron 16 of the ACE gene 6） .
There are some references suggest that use of single nucleotide polymorphisms（SNPs） will contribute to an understanding of differences across racial／ethnic groups 7） . Many studies showed that hereditary and genetic factors, mainly ACE gene mutations in some studies were reported to play a role in the occurrence of essential hypertension. Other studies showed that the DD genotype and D allele associated with essensial hypertension. . reported that the DD genotype was an independent risk factor for the development of hypertension among Hispanics. Freitas et al 21） . reported that increase in systolic blood pressue（SBP） was linked with ACE polymorphysm D allele and old-age in a rural Brazilian population in the Amazon. Bhavani et al 22） reported that a higher incidence of hypertension was observed in the family members of female patients with DD genotype as compared with ID and II. However, inconsistent results have been reported regarding the association of the ACE I／D polymorphism and hypertension 8） . Genotype／allele frequency distribution from ACE I／D gene polymorphism and correlation with hypertension in familiar hypertension in the Javanese population have not been reported. To the best of writer's knowledge, there is no D allele frequency data of population study reported in other ethnic in Indonesia. The Javanese ethnics were located in four provinces in Java island in Indonesia. The four provinces in Java island are East Java, West Java, Central Java, and Yogyakarta Provinces. The present study aims to investigate the ACE I／D gene polymorphism among hypertensive patients with and without history of family hypertension in the Javanese population in Yogyakarta Province, Indonesia.
Materials and Methods
This study was conducted from August 2008 to July 2009 using a cross-sectional study based on population in the Mlati District, Sleman, Yogyakarta, Indonesia. Mlati is a suburban area of the city of Yogyakarta consisting of five villages with a total population of 72, 348. As study subjects, 3 out of 5 villages located in the Mlati were chosen. Subjects were native Javanese Mlati residents in which their parents and grand parents are native Javanese Mlati. Health assistants were trained to measure blood pressure in the Central Health Services or geriatric clinics in the early screening of individuals aged 17─70 years old. The team of researchers also provided training and repeated education to health assistant on how to measure blood pressure properly. Inclusion criteria included：sub-jects>18 years old, essential hypertension and agreement to the study with informed consent. Exclusion criteria were as follows：diabetes mellitus, proteinuria, chronic kidney disease with serum creatinine>1. 4 mg／dl, total cholesterol>250 mg／dl, BMI>25 kg／m 2 , malignancy and pregnancy. In early screening, data were collected from questionnare and performed, including age, sex, hypertension history, place of treatment, hypertensive family history, other disease history such as diabetes mellitus, malignancy and pregnancy. In this early screening, there were 12, 073 study subjects aged 17─70 years. Subjects aged 30─59 years were included in this study. From 12, 073 subjects, 7, 695 individuals were chosen and grouped into normotension, prehypertension, stage 1 and stage 2 hypertension groups. The subjects were taken from the hypertension group with or without a history of hypertension. After randomized stratification, 82 subjects were in the familial hypertensive group and 74 non familial group. The family history of hypertension data were taken from questionnare, first pedigree：siblings, parents, children；second pedigree：uncles, aunts, cousins, grandparents； and third pedigree：nephews and nieces
23）
. The non familial group（control） was a hypertensive group without history of family hypertension. This study has been approved by Ethical Committe Faculty of Medicine Gadjah Mada University, Yogyakarta, Indonesia.
Whole blood was drawn from subjects after informed consent was obtained. Laboratory examination was performed consisting of serum creatinine, lipid profile, serum electrolytes, fasting blood glucose, uric acid and body mass index（BMI）. The ACE genotype（II／ID／DD） polymorphism was examined by the polymerase chain reaction（PCR） in the Biochemical Laboratory, Medical Faculty, Gadjah Mada University, Yogyakarta, Indonesia. The sequence of the forward and reverse primers were sense 5'─CTGGAGACCACTCCCATCCTTTCT─3' and antisense 5'─GATGTGGCCATCACATTCGT-CAGAT─3' 24） . The reaction used 250 ng genomic DNA, 10 mM Tris HCl, 50 mM KCl, 3 mM MgCl 2 , 0.5 mM for each dNTP and 1 unit of Taq DNA polymerase at a final volume of 40 nl：30 cycles of denaturation at 94℃ for 1 minute, annealing at 58℃ for 1 minute and extension at 72℃ for 2 minutes. PCR product of 190 base pair（bp） and 490 bp underwent electrophoresis on agarose gel containing 2％ ethidium bromide and was visualized under UV translumination. The II, DD and ID genotypes were shown by 490 bp, 190bp and both 490 bp and 190 bp bands, respectively （Figure─1） .
Data obtained was analyzed and the mean differences between 2 groups were analyzed by Mann Whitney Test and Student's t─test （p<0. 05；signifi-cant）. Genotypic／allelic distribution in the hypertensive and normotensive groups was analyzed by the Chi Square（| 2 ） test. Statistical significance was taken as p<0. 05.
Results
A total of 156 hypertensive patients were included in this study consisting of 82 in the familial group and 74 in the non familial group. There were 85 males and 71 females with an age range of 30─59 years old. The mean of age in the familial group was 44. 84 ± 7. 75 years and non familial group was 44. 00 ± 7. 21 years（p=0. 485）, as in Table─1. Table─1 also shows that the mean values （mean ± SE） of biochemical parameters, sex, age, systolic and diastolic blood pressure, BMI, lipid profile in the familial and non familial group were not significantly different between the two groups （Student's t─test and Mann Whitney Test）, only DBP in the men familial group（p<0. 05） . Table─2 shows that genotype frequency of ACE gene I／D polymorphism in the familial group（43. 9％ ID； 4. 9％ DD） were significantly higher than that in the non familial group（20. 3％ ID；2. 7％ DD ） （p=0. 002）. Table─2 shows that D allele in the familial group（26. 8％） was significantly higher than that in the non familial group（12. 8％） （p=0. 002）. Table─3 shows that ID genotype frequency of the ACE gene polymorphism（I／D） in males was higher in the familial group than in the non familial group（p=0. 04）. In the female group, the ID genotype in the familial group was higher than in the non familial group（p=0. 04）. Allele frequency distribution （Table─3） in the female group shows that D allele frequency was higher in the familial group than in the non familial group（p=0. 014）. Table─4 shows the genotype frequency of ACE I／D polymorphisms in essential hypertension in different populations in Asia. The association between ACE I／D polymorphisms and hypertension was reported in a Javanese Indonesian population in this study（p=0. 002）, in the Suita Study（Higaki et al. 
Discussion
This study was an investigation the genotype and allele frequencies of ACE I／D polymorphism in familial hypertensive and non familial hypertensive patients among a Javanese population. From the basic data, there were no significant differences between the two groups.
Hypertension has long been recognized to clus- （2004） in Andhra Pradesh, India, reported that genotypes ID, DD and allele D were closely connected with hypertension on males and proved the existence of a link of gene ACE polymorphysm I／D on locus 17q23 with essensial hypertension. The DD genotype in the male group with hypertension with a family history was 52. 2％. The study showed a possible association of ACE D allele with hypertension in men but not in women. A higher incidence of hypertension was observed in the family members of female patients with DD genotype. The study also showed that hypertensive men with the DD genotype and a family history of hypertension were at greater risk than women. Randhawa et al. （2006） reported that there was no association of ACE I／D polymorphism with hypertension in a Punjabi population in India （p>0. 05） 31） . Ashavaid et al. （2000） reported that there was no significant difference between the controls and the hypertensive group and the interaction of the ACE D／D and AT1R A／C genotypes This study showed that the ID and DD genotype frequencies in the hypertensive（familial group） were higher than those in the group with no family history, 43. 9％ vs 20. 3％ ID；4. 9％ vs 7％ DD（p=0. 002）. Genotype frequencies based on sex showed that the ID genotype in the male group and female group with a history of family hypertension was higher than that in the group with no family history. The male group with a family history was 47. 9％ ID compared with 21. 6％ in the male group without family history of hypertension （p=0. 04）. The female group with a family history of hypertension was 38. 2％ ID compared with 18. 9％ without a family history of hypertension （p=0. 04）. The DD genotype in female group with familial hypertension was 5. 9％ compared with 0％ in the group without familial hypertension （p=0. 04）. The D allele in the female group with familial hypertension was higher than the group without familial hypertension, 25. 0％ vs 9. 5％ （p=0. 014） . These studies showed inconsistent results for ACE I／D gene polymorphism among ethnic groups, races and gender in Asia. It is necessary to perform further studies on various populations and multi-ethnic groups, particularly in Indonesia. High D allele frequency in subjects with family history of hypertension showed genetic impact to hypertension in the Javanese Mlati population. The appearance of low DD genotype frequency in the Javanese hypertensive population showed that there is a possibility of a good response to ACE inhibitor（ACE─i） in hypertensive therapy of the Javanese population. For this reason, there should be more follow-up studies on the efficacy of ACE─i in the Javanese population and other ethnic groups in Indonesia （pharmacogenomic study） .
It is concluded that the D allele frequency and ID／DD genotypes were higher in familial hypertensive groups compared with that in non familial hypertensive groups. The ID genotype in male and female groups with a history of family hypertension was higher than that in those with no family history. The D allele in family members of female patients was higher than that in non family members.
